MedPath

Contralateral ReSTOR / Monofocal or Phakic Eye

Phase 4
Completed
Conditions
Cataracts
Interventions
Device: ReSTOR
Registration Number
NCT00731640
Lead Sponsor
Alcon Research
Brief Summary

Bilateral evaluation of unilateral implantation of ReSTOR and contralateral monofocal or phakic eye.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria
  • Unilateral operable cataract
  • Candidate for presbyopic intraocular lens (IOL)
Exclusion Criteria
  • Ocular comorbidities compromising primary outcome
  • Bilateral cataracts

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MonofocalReSTORPatients unilaterally implanted with ReSTOR lens in one eye and previously implanted with monofocal Intraocular lens (IOL) (unspecified) in other eye
PhakicReSTORPatients unilaterally implanted with ReSTOR lens in one eye and phakic in the other eye with no necessary cataract removal impending
Primary Outcome Measures
NameTimeMethod
Visual Acuity6 months

Uncorrected Visual Acuity (VA) is measured in logMAR. LogMAR is the "logarithm of the minimum angle of resolution". A lower logMAR value indicates better visual acuity.

Secondary Outcome Measures
NameTimeMethod
Contrast Sensitivity6 Months

Contrast sensitivity is the measurement of one's ability to detect slight changes in luminance before it becomes indistinguishable. It is measured in logarithmic (log) units by means of an illuminated box, the CSV 1000 by Vector Vision. A higher value for the logarithmic units translates to better contrast sensitivity.

Patient Satisfaction6 Months Postoperative

Average rating of patient satisfaction based on a patient survey. The survey had a 10 point scale (10 being most satisfied and 0 being most unsatisfied).

Spectacle Independence6 Months

The percentage of patients reporting spectacle independence (no longer needing to wear glasses).

Trial Locations

Locations (1)

Alcon Call Center for Trial Locations

🇺🇸

Fort Worth, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath